Skip to main content

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Kura Oncology, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of KURA: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders1481480
Shares68.7M71.6M+2.90M (+4.2%)
Value$1.26B$977.5M−$281.0M (−22.3%)

New holders (19)

Institutions that held Kura Oncology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to KURA in Q3 2022
InstitutionSharesValue% of portfolio
T. Rowe Price Investment Management, Inc.2,572,169$35.1M0.03%
Walleye Capital LLC268,074$3.66M0.08%
Susquehanna International Group, LLP108,370$1.48M0.00%
Connor, Clark & Lunn Investment Management Ltd.53,240$727.0K0.00%
Jump Financial, LLC51,241$700.0K0.03%
TD Asset Management Inc40,040$533.0K0.00%
Walleye Trading LLC33,220$454.0K0.01%
Aquatic Capital Management LLC25,400$347.0K0.03%
Teacher Retirement System of Texas18,532$253.0K0.00%
Point72 Hong Kong Ltd15,754$215.0K0.01%
Gsa Capital Partners LLP14,497$198.0K0.03%
American Century Companies Inc10,355$141.0K0.00%
Annandale Capital, LLC10,000$137.0K0.05%
Allspring Global Investments Holdings, LLC860$11.0K0.00%
China Universal Asset Management Co., Ltd.626$9.00K0.00%
Wipfli Financial Advisors LLC,424$6.00K0.00%
The PNC Financial Services Group, Inc.160$2.00K0.00%
CWM, LLC32$00.00%
Covestor Ltd8$00.00%

Sold out (19)

Institutions that held Kura Oncology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.